Clinical and Pharmacokinetic Risk Factors for High-dose Methotrexate-induced Toxicity in Children with Acute Lymphoblastic Leukemia: A Logistic Regression Analysis

Authors

Charlotte Rask
Freidoun Albertioni From the Department of Pediatrics, Aarhus University Hospital, Denmark (C. Rask, H. Schroeder), the Department of Clinical Pharmacology, Karolinska Hospital, Stockholm, Sweden, (F. Albertioni, C. Peterson), and the Danish Cancer Society, Department of Experimental Clinical Oncology Aarhus University Hospital, Denmark (S. M. Bentzen)
Soeren M. Bentzen From the Department of Pediatrics, Aarhus University Hospital, Denmark (C. Rask, H. Schroeder), the Department of Clinical Pharmacology, Karolinska Hospital, Stockholm, Sweden, (F. Albertioni, C. Peterson), and the Danish Cancer Society, Department of Experimental Clinical Oncology Aarhus University Hospital, Denmark (S. M. Bentzen)
Henrik Schroeder From the Department of Pediatrics, Aarhus University Hospital, Denmark (C. Rask, H. Schroeder), the Department of Clinical Pharmacology, Karolinska Hospital, Stockholm, Sweden, (F. Albertioni, C. Peterson), and the Danish Cancer Society, Department of Experimental Clinical Oncology Aarhus University Hospital, Denmark (S. M. Bentzen)
Curt Peterson From the Department of Pediatrics, Aarhus University Hospital, Denmark (C. Rask, H. Schroeder), the Department of Clinical Pharmacology, Karolinska Hospital, Stockholm, Sweden, (F. Albertioni, C. Peterson), and the Danish Cancer Society, Department of Experimental Clinical Oncology Aarhus University Hospital, Denmark (S. M. Bentzen)

No Abstract Available

Download data is not yet available.

No Abstract Available